VSTM

Latest SEC Filings & News for VSTM

2 most recent filings and news items mentioning VSTM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/VSTM/news?limit=20"

Pull VSTM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJun 23, 2026Positive

Verastem announces R&D update for VS-7375 KRAS inhibitor

Verastem hosted an R&D update call discussing the KRAS G12D inhibitor VS-7375. This information is relevant for investors assessing the company's potential pipeline opportunities in the oncology space.

View filing at SEC.gov →

RegulatoryJun 17, 2026Positive

Verastem reports 86% 6-month OS rate in RAMP 205 pancreatic cancer trial

Verastem Oncology announced positive updated results from RAMP 205 evaluating avutometinib plus defactinib combined with standard chemotherapy in first-line metastatic pancreatic cancer, showing an 86% overall survival rate at 6 months and 52% objective response rate. The encoura

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.